Enanta Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Enanta Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Enanta Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enanta Pharmaceuticals by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $928k | 78k | 11.97 |
| 2025-06-30 | $112k | 15k | 7.56 |
| 2025-03-31 | $168k | 31k | 5.52 |
| 2024-12-31 | $142k | 25k | 5.75 |
| 2024-09-30 | $122k | 12k | 10.36 |
| 2024-03-31 | $779k | 45k | 17.46 |
| 2023-12-31 | $389k | 41k | 9.41 |
| 2022-09-30 | $265k | 5.1k | 51.86 |
| 2020-06-30 | $498k | 9.9k | 50.25 |
| 2019-09-30 | $478k | 8.0k | 60.13 |
| 2019-06-30 | $224k | 2.7k | 84.53 |
| 2018-12-31 | $220k | 3.1k | 70.97 |
| 2018-09-30 | $367k | 4.3k | 85.35 |
| 2014-12-31 | $312k | 5.3k | 58.87 |
| 2014-09-30 | $420k | 9.5k | 44.21 |
| 2014-03-31 | $441k | 10k | 44.10 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management